Serica Energy PLC (SQZ)
London Exchange · UK · prices in GBX · close of 23 Oct 2026
Key indicators
| Last close | GBX 269.60 |
|---|---|
| 52-week range | 162.19 – 302.40 |
| Return, 1 month / 3 months | −2.1% / +4.7% |
| Return, 1 year / 3 years | +44.0% / +58.9% |
| Trend | Uptrend |
| RSI (14) | 51 |
| Volatility (1 year) | 49.0% |
| Worst drawdown (1 year) | -25.8% |
| Average daily value traded | 365.64M GBX |
| Dividend yield | 8.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Serica Energy is an independent oil and gas company based in London that produces hydrocarbons from fields in the UK North Sea. It operates and holds interests in a portfolio of offshore assets, including the Bruce, Keith, Rhum and Erskine fields, and sells its oil and gas output into energy markets. The company also holds exploration and development interests in the same region, and its customers are the buyers and traders of North Sea crude and natural gas.
On this site Serica Energy PLC appears as a stock on the London Exchange (UK), code SQZ, with prices in pence sterling (GBX). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Serica Energy PLC (SQZ) trades on the London Exchange in UK. It last closed at GBX 269.60 on 23 October 2026.
Its price-based Market X-Ray is 68 out of 100 (a fair price profile), ranking 642 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 44.0% and over the last three months it rose 4.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 76 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 10.3% | ||
| From 52-week high | -8.3% | ||
| Momentum | 71 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 4.7% | ||
| 6-month return | 3.7% | ||
| 12-month return, skipping the last month | 47.1% | ||
| Stability (higher is calmer) | 43 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 49.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -25.8% | ||
| Liquidity | 94 · Strong | Trades actively. | |
| Average daily value traded | 365.64M GBX | ||
| Zero-volume days | 0.0% | ||
| Income | 66 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 8.2% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | −3.7% |
|---|---|
| 1 month | −2.1% |
| 3 months | +4.7% |
| 6 months | +3.7% |
| 1 year | +44.0% |
| 3 years | +58.9% |
| 5 years | +83.7% |
Signals
| 50-day / 200-day average | 265.08 / 244.37 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 11.26 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 22 Oct 2026 | GBP 0.0600 |
| 25 Jun 2026 | GBP 0.1000 |
| 23 Oct 2025 | GBP 0.0600 |
| 26 Jun 2025 | GBP 0.1000 |
| 24 Oct 2024 | GBP 0.0900 |
| 27 Jun 2024 | GBP 0.1400 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.